Cited by 497Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and PathologyNuclear Receptors and Signaling

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Open access

Tieu, Kim, Perier, Celine, Caspersen, Casper, Teismann, Peter, Wu, Du-Chu, Yan, Shi-Du, Naini, Ali, Vila, Miquel, Jackson-Lewis, Vernice, Ramasamy, Ravichandran, Przedborski, Serge·2003·Journal of Clinical Investigation

DOI 10.1172/jci200318797PMC PMC193668

Open this paper in CoChat — free account Open PDF

Abstract

Parkinson disease (PD) is a neurodegenerative disorder characterized by a loss of the nigrostriatal dopaminergic neurons accompanied by a deficit in mitochondrial respiration. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes dopaminergic neurodegeneration and a mitochondrial deficit reminiscent of PD. Here we show that the infusion of the ketone body D-β-hydroxybutyrate (DβHB) in mice confers partial protection against dopaminergic neurodegeneration and motor deficits induced by MPTP. These effects appear to be mediated by a complex II–dependent mechanism that leads to improved mitochondrial respiration and ATP production. Because of the safety record of ketone bodies in the treatment of epilepsy and their ability to penetrate the blood-brain barrier, DβHB may be a novel neuroprotective therapy for PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci200318797

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Brain Metabolism during Fasting*
Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,662
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264
Generation of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Self-citation
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010
Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake
Anson, R. M., Guo, Z., de Cabo, R., Iyun, T., Rios, M., Hagepanos, A., Ingram, D. K., Lane, M. A., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035720100 · Cited by 732

Show all 43 references

Research works printed but not linked: 2

Giovanni, 1991, J. Pharmacol. Exp. Ther., 257, 691
Plecko, 2002, Pediatr. Res., 52, 301

Sorted by citations

Items 101–200 of 497

β-Hydroxybutyrate: A signaling metabolite in starvation response?
Rojas‐Morales, P., Tapia, E., & Pedraza‐Chaverrí, J. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.04.005 · Cited by 147
β-hydroxybutyrate and its metabolic effects on age-associated pathology
Han, Y., Ramprasath, T., & Zou, M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0415-z · Cited by 140
β-hydroxybutyrate as an Anti-Aging Metabolite
Wang, L. Y., Chen, P., & Xiao, W. (2021) · Nutrients · doi:10.3390/nu13103420 · Cited by 135
The ketogenic diet and epilepsy
‍Kim, D. Y., & Rho, J. M. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f44c06 · Cited by 133
Mitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131
Self-citation
Identity of SMCT1 (SLC5A8) as a neuron‐specific Na+‐coupled transporter for active uptake of l ‐lactate and ketone bodies in the brain
Martin, P. M., Gopal, E., Ananth, S., Zhuang, L., Itagaki, S., Prasad, B. M., Smith, S. B., Prasad, P. D., & Ganapathy, V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03878.x · Cited by 132
3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism
Zhang, J., Cao, Q., Li, S., Lu, X., Zhao, Y., Guan, J., Chen, J., Wu, Q., & Chen, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.043 · Cited by 130
Ketogenic Diets for Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0666-8 · Cited by 137
The protective role of PHB and its degradation products against stress situations in bacteria
Müller‐Santos, M., Koskimäki, J. J., Alves, L. P. S., de Souza, E. M., Jendrossek, D., & Pirttilä, A. M. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa058 · Cited by 126
Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults
Escartin, C., Pierre, K., Colin, A., Brouillet, E., Delzescaux, T., Guillermier, M., Dhénain, M., Déglon, N., Hantraye, P., Pellerin, L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0174-07.2007 · Cited by 126
Liver-derived ketone bodies are necessary for food anticipation
Chavan, R., Feillet, C. A., Costa, S. S., Delorme, J. E., Okabe, T., Ripperger, J. A., & Albrecht, U. (2016) · Nature Communications · doi:10.1038/ncomms10580 · Cited by 127
Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
Bai, X., Tang, Y., Yu, M., Wu, L., Liu, F., Ni, J., Wang, Z., Wang, J., Fei, J., Wang, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03887-3 · Cited by 124
Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
Han, R., Liang, J., & Zhou, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115887 · Cited by 125
Neuroprotection by the Ketogenic Diet: Evidence and Controversies
Gough, S. M., Casella, A., Ortega, K. J., & Hackam, A. S. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.782657 · Cited by 122
The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats
Zhao, Y., Zou, B., Shi, Z., Wu, Q., & Chen, G. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.003 · Cited by 119
Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson’s model
Ray, A., Martinez, B., Berkowitz, L. A., Caldwell, G. A., & Caldwell, K. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.513 · Cited by 118
Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents
Streijger, F., Plunet, W. T., Lee, J. H. T., Liu, J., Lam, C. K., Park, S., Hilton, B. J., Fransen, B. L., Matheson, K. A. J., Assinck, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078765 · Cited by 117
Muscle-to-Brain Signaling Via Myokines and Myometabolites
Rai, M., & Demontis, F. (2022) · Brain Plasticity · doi:10.3233/bpl-210133 · Cited by 126
Metabolic Messengers: ketone bodies
Nelson, A. B., Queathem, E. D., Puchalska, P., & Crawford, P. A. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00935-3 · Cited by 118
Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives
Ren, Q., Ruth, K., Thöny-Meyer, L., & Zinn, M. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2530-6 · Cited by 113
Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors
Kim, D. Y., Vallejo, J., & Rho, J. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06728.x · Cited by 113
Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease
Cheng, B., Yang, X., An, L., Gao, B., Liu, X., & Liu, S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.060 · Cited by 113
Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders
Soane, L., Kahraman, S., Kristián, T., & Fiskum, G. M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21498 · Cited by 112
Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism
Kosaraju, J., Chinni, S., Roy, P., Kannan, E., Antony, A., & Kumar, M. N. S. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.129312 · Cited by 113
The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease
Norwitz, N. G., Hu, M. T., & Clarke, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00063 · Cited by 110
In vitro effect of oligo-hydroxyalkanoates on the growth of mouse fibroblast cell line L929
Sun, J., Dai, Z., Zhao, Y., & Chen, G. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.011 · Cited by 110
The effect of d,l-β-hydroxybutyric acid on cell death and proliferation in L929 cells
Cheng, S., Chen, G., Leski, M. L., Zou, B., Wang, Y., & Wu, Q. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.02.046 · Cited by 110
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 116
Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases
Jang, J., Kim, S. R., Lee, J. E., Lee, S.-Y., Son, H. J., Choe, W., Yoon, K., Kim, S. S., Yeo, E., & Kang, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010124 · Cited by 116
Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Harun‐Or‐Rashid, M., Pappenhagen, N., Palmer, P. G., Smith, M. A., Gevorgyan, V., Wilson, G. N., Crish, S. D., & Inman, D. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3652-17.2018 · Cited by 104
Mitochondrial respiration as a target for neuroprotection and cognitive enhancement
Gonzalez-Lima, F., Barksdale, B. R., & Rojas, J. C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.010 · Cited by 105
Effects of Calorie Restriction on Health Span and Insulin Resistance: Classic Calorie Restriction Diet vs. Ketosis-Inducing Diet
Napoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer
Hwang, C. Y., Choe, W., Yoon, K., Ha, J., Kim, S. S., Yeo, E., & Kang, I. (2022) · Nutrients · doi:10.3390/nu14224932 · Cited by 115
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 100
α-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2
Kett, L. R., Stiller, B., Bernath, M. M., Tasset, I., Blesa, J., Jackson-Lewis, V. R., Chan, R., Zhou, B., Paolo, G. D., Przedborski, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0632-14.2015 · Cited by 103
Self-citation
Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: Attenuation by a lipophilic metalloporphyrin
Liang, L., Waldbaum, S., Rowley, S. D., Huang, T., Day, B. J., & Patel, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.025 · Cited by 100
Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans
Sammi, S. R., Foguth, R. M., Nieves, C. S., De Perre, C., Wipf, P., McMurray, C. T., Lee, L. S., & Cannon, J. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz191 · Cited by 93
Interactions between a poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) terpolyester and human keratinocytes
Ji, Y., Li, X., & Chen, G. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.06.008 · Cited by 98
Gestational ketogenic diet programs brain structure and susceptibility to depression & anxiety in the adult mouse offspring
Sussman, D., Germann, J., & Henkelman, R. M. (2014) · Brain and Behavior · doi:10.1002/brb3.300 · Cited by 102
Polyhydroxyalkanoates as biomaterial for electrospun scaffolds
Sanhueza, C., Acevedo, F., Rocha, S., Villegas, P., Seeger, M., & Navia, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.068 · Cited by 96
D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
Lim, S., Chesser, A. S., Grima, J. C., Rappold, P. M., Blum, D. L., Przedborski, S., & Tieu, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024620 · Cited by 94
Self-citation
Fasting as a Therapy in Neurological Disease
Phillips, M. C. L. (2019) · Nutrients · doi:10.3390/nu11102501 · Cited by 99
Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration
Li, R., Liu, Y., Liu, H., & Li, J. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13140 · Cited by 97
Function and mechanism of histone β-hydroxybutyrylation in health and disease
Zhou, T., Cheng, X., He, Y., Xie, Y., Xu, F., Xu, Y., & Huang, W. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981285 · Cited by 104
Current perspective of mitochondrial biology in Parkinson's disease
Kaidery, N. A., & Thomas, B. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.03.001 · Cited by 95
The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases
Redmann, M., Darley-Usmar, V. M., & Zhang, J. (2016) · Aging and Disease · doi:10.14336/ad.2015.0820 · Cited by 93
Iron‐sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease
Liang, L., & Patel, M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02567.x · Cited by 90
Post-Translational Oxidative Modification and Inactivation of Mitochondrial Complex I in Epileptogenesis
Ryan, K., Backos, D. S., Reigan, P., & Patel, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0907-12.2012 · Cited by 91
The effect of 3-hydroxybutyrate and its derivatives on the growth of glial cells
Xiao, X.-Q., Zhao, Y., & Chen, G. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.046 · Cited by 89
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Potential Therapeutic Use of the Ketogenic Diet in Autism Spectrum Disorders
Napoli, E., DueÃ±as, N., & Giulivi, C. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00069 · Cited by 96
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.013 · Cited by 87
Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation
Offermanns, S., & Schwaninger, M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.002 · Cited by 91
Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla
Hou, W., Lin, R., Chen, C.-T., & Lee, M. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.03.017 · Cited by 85
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Mamelak, M. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0091-2 · Cited by 84
In Vivo Complementation of Complex I by the Yeast Ndi1 Enzyme
Seo, B. B., Nakamaru‐Ogiso, E., Flotte, T. R., Matsuno‐Yagi, A., & Yagi, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600922200 · Cited by 86
Conformation-specific Binding of α-Synuclein to Novel Protein Partners Detected by Phage Display and NMR Spectroscopy
Woods, W. S., Boettcher, J. M., Zhou, D. H., Kloepper, K. D., Hartman, K. L., Ladror, D. T., Qi, Z., Rienstra, C. M., & George, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705283200 · Cited by 83
The Combined Influences of Exercise, Diet and Sleep on Neuroplasticity
Pickersgill, J. W., Turco, C. V., Ramdeo, K. R., Rehsi, R. S., Foglia, S. D., & Nelson, A. J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.831819 · Cited by 92
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
Mounsey, R. B., & Teismann, P. (2010) · Parkinson s Disease · doi:10.4061/2011/617472 · Cited by 86
Self-citation
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis
Storoni, M., & Plant, G. T. (2015) · Multiple Sclerosis International · doi:10.1155/2015/681289 · Cited by 80
SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature
Jiang, Y., Brynskikh, A. M., Manickam, D. S., & Kabanov, A. V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.021 · Cited by 80
D‐β‐hydroxybutyrate promotes functional recovery and relieves pain hypersensitivity in mice with spinal cord injury
Qian, J., Zhu, W., Lü, M., Ni, B., & Yang, J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13788 · Cited by 82
Calcium‐dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons
Hernández‐Fonseca, K., Cárdenas‐Rodríguez, N., Pedraza‐Chaverrí, J., & Massieu, L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21634 · Cited by 79
D ‐β‐hydroxybutyrate is neuroprotective against hypoxia in serum‐free hippocampal primary cultures
Masuda, R., Monahan, J. W., & Kashiwaya, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20464 · Cited by 79
Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells
Kweon, G., Marks, J. D., Krencik, R., Leung, E. H., Schumacker, P. T., Hyland, Κ., & Kang, U. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407336200 · Cited by 77
Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention
Gross, E. C., Klement, R. J., Schoenen, J. E., D’Agostino, D. P., & Fischer, D. (2019) · Nutrients · doi:10.3390/nu11040811 · Cited by 78
Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future
Evans, M., McClure, T. S., Koutnik, A. P., & Egan, B. (2022) · Sports Medicine · doi:10.1007/s40279-022-01756-2 · Cited by 84
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms
Perier, C., Bender, A., García‐Arumí, E., Melia, M., Bové, J., Laub, C., Klopstock, T., Elstner, M., Mounsey, R. B., Teismann, P., et al. (2013) · Brain · doi:10.1093/brain/awt196 · Cited by 75
Self-citation
Methyl-esterified 3-hydroxybutyrate oligomers protect bacteria from hydroxyl radicals
Koskimäki, J. J., Kajula, M., Hokkanen, J., Ihantola, E., Jong Heon, K. I. M., Hautajärvi, H., Hankala, E., Suokas, M., Pohjanen, J., Podolich, O. V., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2043 · Cited by 78
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists
Barrea, L., Megna, M., Cacciapuoti, S., Frías-Toral, E., Fabbrocini, G., Savastano, S., Colao, A., & Muscogiuri, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1818053 · Cited by 75
Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease
Zhang, J., Culp, M. L., Craver, J., & Darley-Usmar, V. M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14308 · Cited by 74
Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy–Lysosomal Pathway
Gómora‐García, J. C., Montiel, T., Hüttenrauch, M., Salcido-Gómez, A., García‐Velázquez, L., Ramiro‐Cortés, Y., Gómora, J. C., Castro‐Obregón, S., & Massieu, L. (2023) · Cells · doi:10.3390/cells12030486 · Cited by 75
How Can a Ketogenic Diet Improve Motor Function?
Veyrat‐Durebex, C., Reynier, P., Procaccio, V., Hergesheimer, R. C., Corcia, P., Andres, C. R., & Blasco, H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00015 · Cited by 72
The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome
Shang, S., Wang, L., Zhang, Y., Lü, H., & Lu, X. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0617-2 · Cited by 71
Nutritional and metabolic support in patients with amyotrophic lateral sclerosis
Muscaritoli, M., Kushta, I., Molfino, A., Inghilleri, M., Sabatelli, M., & Fanelli, F. R. (2012) · Nutrition · doi:10.1016/j.nut.2012.01.011 · Cited by 70
Ketogenic Diet for the Treatment and Prevention of Dementia: A Review
Davis, J. J., Fournakis, N. A., & Ellison, J. M. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720901785 · Cited by 73
Environmental toxins and Parkinson’s disease: Putative roles of impaired electron transport chain and oxidative stress
Arif, I. A., & Khan, H. A. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233710362382 · Cited by 68
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 80
The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy
Ruskin, D. N., & Masino, S. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00033 · Cited by 67
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
Rajda, C., Pukoli, D., Bende, Z., Majláth, Z., & Vécsei, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020353 · Cited by 69
Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 68
Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men
Kraeuter, A.-K., Phillips, R., & Sarnyai, Z. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109913 · Cited by 67
Brain glucose and ketone utilization in brain aging and neurodegenerative diseases
Kapogiannis, D., & Avgerinos, K. I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.015 · Cited by 64
Influence of dl -β-Hydroxybutyric Acid on Cell Proliferation and Calcium Influx
Cheng, S., Wu, Q., Yang, F., Xu, M. M., Leski, M. L., & Chen, G. (2004) · Biomacromolecules · doi:10.1021/bm049465y · Cited by 62
The ketogenic diet in disease and development
Barry, D., Ellul, S., Watters, L., Lee, D. J., Haluska, R. J., & White, R. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.04.005 · Cited by 62
Augmenting brain metabolism to increase macro- and chaperone-mediated autophagy for decreasing neuronal proteotoxicity and aging
Loos, B., Klionsky, D. J., & Wong, E. S. P. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.001 · Cited by 64
d -β-Hydroxybutyrate Protects against Corneal Epithelial Disorders in a Rat Dry Eye Model with Jogging Board
Nakamura, S., Shibuya, M., Nakashima, H., Imagawa, T., Uehara, M., & Tsubota, K. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1344 · Cited by 61
The efficacy of the ketogenic diet on motor functions in Parkinson's disease: A rat model.
Shaafi, S., Najmi, S., Aliasgharpour, H., Mahmoudi, J., Sadigh-Etemad, S., Farhoudi, M., & Baniasadi, N. (2016) · Europe PMC (PubMed Central) · Cited by 59
Interventions that Improve Body and Brain Bioenergetics for Parkinson's Disease Risk Reduction and Therapy
Mattson, M. P. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130335 · Cited by 60
Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice
Kraeuter, A.-K., Mashavave, T., Suvarna, A., van den Buuse, M., & Sarnyai, Z. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05467-2 · Cited by 63
Apoptosis‐inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins
Perier, C., Bové, J., Dehay, B., Jackson-Lewis, V. R., Rabinovitch, P. S., Przedborski, S., & Vila, M. (2010) · Annals of Neurology · doi:10.1002/ana.22034 · Cited by 58
Self-citation
Control of seizures by ketogenic diet-induced modulation of metabolic pathways
Clanton, R., Wu, G., Akabani, G., & Aramayo, R. (2016) · Amino Acids · doi:10.1007/s00726-016-2336-7 · Cited by 61
Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome
Zhang, W., Chen, S., Huang, X., Tong, H., Niu, H., & Lu, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01549-0 · Cited by 60
Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
Liu, J., Huang, D., Xu, J., Tong, J., Wang, Z., Huang, L., Yang, Y., Bai, X., Wang, P., Suo, H., et al. (2015) · Scientific Reports · doi:10.1038/srep15720 · Cited by 57
A Ketogenic Diet in Rodents Elicits Improved Mitochondrial Adaptations in Response to Resistance Exercise Training Compared to an Isocaloric Western Diet
Hyatt, H. W., Kephart, W. C., Holland, A. M., Mumford, P. W., Mobley, C. B., Lowery, R. P., Roberts, M. D., Wilson, J. M., & Kavazis, A. N. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00533 · Cited by 57
Chronic in vitro ketosis is neuroprotective but not anti‐convulsant
Samoilova, M., Weisspapir, M., Abdelmalik, P. A., Velumian, A. A., & Carlen, P. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06645.x · Cited by 54
L ‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's disease
Tieu, K., Perier, C., Vila, M., Caspersen, C. S., Zhang, H., Teismann, P., Jackson-Lewis, V. R., Stern, D. M., Yan, S. D., & Przedborski, S. (2004) · Annals of Neurology · doi:10.1002/ana.20133 · Cited by 55
Self-citation
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Tribble, J. R., Hui, F., Jöe, M., Bell, K. C., Chrysostomou, V., Crowston, J. G., & Williams, P. A. (2021) · Cells · doi:10.3390/cells10020295 · Cited by 56
Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles
Khasnavis, S., Roy, A., Ghosh, S., Watson, R. L., & Pahan, K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9503-3 · Cited by 54

Authors: Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., & Przedborski, S.
Affiliations: Columbia University (US)
Corresponding author: Przedborski, Serge
ORCID: Tieu, Kim
Naini, Ali
Vila, Miquel
Ramasamy, Ravichandran
Przedborski, Serge
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2003-09-15
Volume: 112
Issue: 6
Pages: 892-901
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200318797
PMC: PMC193668
OpenAlex: W4242174061
Cited by: 497
References: 43
Citations by year: 2026: 23 · 2025: 35 · 2024: 24 · 2023: 24 · 2022: 44 · 2021: 30 · 2020: 33 · 2019: 25 · 2018: 34 · 2017: 32 · 2016: 23 · 2015: 15 · 2014: 21 · 2013: 10 · 2012: 10
FWCI: 7.79
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
KU ScholarWorks (The University of Kansas) (submittedVersion, other-oa)
Funders: National Institutes of Health (5r29ns037345-05)
National Institute of Neurological Disorders and Stroke (P50-NS38370, R01 NS 38586, R01 NS 42269, R29 NS37345, P01NS011766, R01NS042269, R01NS038586, P50NS038370, P01 NS11766-27A1)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: D-β-hydroxybutyrate, ketone bodies, Parkinson's disease, mitochondrial respiration, MPTP-induced neurotoxicity, dopaminergic neuron loss, complex II, neuroprotection, motor impairment, ATP production, blood-brain barrier
MeSH terms: Adenosine Triphosphate, Animals, Brain, Dopamine, Electron Transport, Humans, Hydrogen Peroxide, Hydroxybutyrate Dehydrogenase, Male, Mice, Inbred C57BL, Mitochondria, Motor Activity, NAD, NADH, NADPH Oxidoreductases, Neurons, Oxygen, Parkinson Disease, Tyrosine 3-Monooxygenase, Dopamine Agents, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Oxidants, Neuroprotective Agents, Cell Respiration, 3-Hydroxybutyric Acid, Electron Transport Complex I, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks